ATC

ATC-Index M05BX04

You are here: Startseite > ATC > M > M05 > M05B > M05BX

- ATC
Anatomisch-therapeutisch-chemische-Klassifikation mit Tagesdosen (ATC)
- M
MUSKEL- UND SKELETTSYSTEM
- M05
MITTEL ZUR BEHANDLUNG VON KNOCHENERKRANKUNGEN
- M05B
MITTEL MIT EINFLUSS AUF DIE KNOCHENSTRUKTUR UND DIE MINERALISATION
- M05BX
Andere Mittel mit Einfluss auf die Knochenstruktur und die Mineralisation

M05BX04

Denosumab

ATC Code M05BX04 für Denosumab

DDD info: 0,33 mg P; 0,12 g P Dosis pro Behandlungszyklus bei skelettbezogenen Komplikationen mit Knochenmetastasen
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us